A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

ClinicalTrials.gov ID: NCT05164172

Public ClinicalTrials.gov record NCT05164172. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 10, 2026, 6:52 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Long-term, Open-label (Dose-blinded), Extension Study of Eptinezumab in Children and Adolescents With Chronic or Episodic Migraine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main goal of the study is to assess the long-term safety of eptinezumab on children and adolescents ages 6 to 17 with chronic or episodic migraine.

Study identification

NCT ID: NCT05164172
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: H. Lundbeck A/S; Industry
Enrollment: 600 participants

Conditions and interventions

Conditions

Migraine

Interventions

Eptinezumab Drug

Drug

Eligibility (public fields only)

Age range: 6 Years to 17 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 1, 2021 (Actual)
Primary completion: Apr 30, 2028 (Estimated)
Completion: Apr 30, 2028 (Estimated)
Last update posted: Oct 14, 2026

2021 – 2028

United States locations

U.S. sites: 20
U.S. states: 12
U.S. cities: 20

Facility	City	State	ZIP	Site status
Yale School of Medicine - The Scirex Clinical Research Unit	New Haven	Connecticut	06519-1405	Recruiting
New England Institute for Clinical Research (NEICR) - Stamford	Stamford	Connecticut	06905-1206	Recruiting
Sarkis Clinical Trials - Gainsville	Gainesville	Florida	32607	Completed
NW FL Clinical Research Group, LLC	Gulf Breeze	Florida	32561-4495	Recruiting
AGA Clinical Trials	Hialeah	Florida	33012-3407	Recruiting
Axcess Medical Research - Loxahatchee	Loxahatchee Groves	Florida	33470-9206	Completed
University of South Florida (USF) - Tampa Campus	Tampa	Florida	33620	Recruiting
University of Kentucky (UK) - Markey Cancer Center	Lexington	Kentucky	40536-0002	Recruiting
University of Maryland School of Medicine	Baltimore	Maryland	21201-1509	Recruiting
Michigan Headache & Neurological Institute (MHNI)	Ann Arbor	Michigan	48104-5131	Completed
Corewell Health - Helen DeVos Children's Hospital (HDVCH) - Medical Genetics	Grand Rapids	Michigan	49503	Completed
Dent Neurosciences Research Center	Amherst	New York	14226-1727	Completed
True North Neurology - Commack (North Suffolk Neurology)	Commack	New York	11725-2850	Recruiting
OnSite Clinical Solutions, LLC - Charlotte	Charlotte	North Carolina	28210-0106	Completed
Akron Children's Hospital	Akron	Ohio	44308-1062	Recruiting
Cincinnati Children's Hospital Medical Center-Burnet Campus	Cincinnati	Ohio	45229-3026	Recruiting
Road Runner Research (RRR)	San Antonio	Texas	78249-3539	Recruiting
Children's Specialty Group (CSG)	Norfolk	Virginia	23510	Recruiting
Marshall Health-Marshall University Medical Center	Huntington	West Virginia	25701-3656	Recruiting
Children's Wisconsin (Children's Hospital of Wisconsin)-Main Campus	Milwaukee	Wisconsin	53226	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05164172, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 14, 2026 · Synced Nov 10, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05164172 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →